|
Post by buyitonsale on May 22, 2016 23:53:26 GMT -5
Yes, there is a plan. There were comments / questions from the audience re DTC to drive demand. Mike emphasized that this would not be cost-effective at this point. He also emphasized that physicians have to be educated - how to prescribe, spiro requirement, titration, simplifying the prior auth, etc - all before patients spike the demand. This is where he is picking up the ball that SNY dropped. Toward this initial goal: * The cadre of diabetic nurse educators * Making available a low cost spirometer and educating physicians that they don't need a full pulmonary function test * A hotline for prior auth's - so that the physicians's office will receive a simple form tailored to the pt's specific insurance * New titration sample boxes and instruction in how to accomplish it What you are implying is that there is a foregone conclusion that the "plan" is not going to bring substantial revenue to sustain the company beyond the cash reserves are depleted. In a business plan, a business owner projects revenues and expenses for a certain period of time and describes operational activity and costs related to the business. I would like to know at least the projected TRx per week by the end of 3rd quarter. Would be nice to know the projected revenue and expenses as well, if it's not too much trouble. Why? Because we have only enough money to last until December. And, If Mike's team cannot achieve at least half the Rx counts that are needed to sustain the company beyond December, they will need another round of unfavorable financing.
|
|